Company Filing History:
Years Active: 2010-2014
Title: Mark Lynch - Innovator in Medical Treatments
Introduction
Mark Lynch is a notable inventor based in Madison, CT (US), recognized for his contributions to medical treatments through innovative patent developments. He holds a total of 3 patents, showcasing his commitment to advancing healthcare solutions.
Latest Patents
One of his latest patents is titled "Diaryl ureas for diseases mediated by PDGFR." This invention provides methods for treating and preventing conditions associated with platelet-derived growth factor receptor (PDGFR) pathways. It includes devices and methods aimed at treating restenosis following angioplastic surgery and graft rejection after tissue transplantation. Another significant patent is "Substituted thieno[3,2-D]pyrimidines as Rho kinase inhibitors." This patent discloses compounds that inhibit Rho-kinase, which are useful for treating various conditions, including tumor growth and erectile dysfunction.
Career Highlights
Mark Lynch is currently employed at Bayer Healthcare LLC, where he continues to develop innovative solutions in the medical field. His work focuses on creating effective treatments that address critical health issues.
Collaborations
Throughout his career, Mark has collaborated with notable colleagues, including Uday R Khire and Davoud Asgari, enhancing the impact of his inventions through teamwork and shared expertise.
Conclusion
Mark Lynch's contributions to medical innovation through his patents reflect his dedication to improving health outcomes. His work at Bayer Healthcare LLC and his collaborations with other professionals further amplify his impact in the field.